ENTITY
Merck & Co

Merck & Co (MRK US)

192
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
Refresh
bullishS&P 500 INDEX
12 Dec 2019 21:11

U. S. Equity Strategy: Small-Caps Closing the Gap

Major averages in the US (S&P 500, Dow, Russell 2000) and Europe (STOXX 600 & 50) each had throwbacks to their prior breakout levels last...

Logo
430 Views
Share
03 Aug 2019 13:09

ECM Weekly (3 Aug 2019) - Sterling&Wilson, Spandana Sphoorty, Smoore, AllHome, JS Global

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bullishAlphamab Co Ltd
30 Jul 2019 17:39

Alphamab IPO: Interims from Merck's Breast Cancer Trial Bodes Well for Alphamab and Junshi

Last night, Merck & Co Inc. (MRK US) announced that its Keytruda hits primary endpoint in Phase III (KEYNOTE-522) clinical trial in the...

Logo
561 Views
Share
17 Jun 2019 11:22

This Week in Blockchain & Cryptos: Visa, Ubisoft, GM, Target, FB & Apple Reveal Blockchain Plans

Bitcoin saw a correction during the first week of June but has recovered quickly. Bitcoin's leading indicators remain positive, giving a bullish...

Logo
580 Views
Share
12 Jun 2019 10:05

Immuno-Oncology Drugs in Adjuvant Lung: The Next Frontier in Strengthening Moats

The potential for Merck and Roche looks underappreciated.Innovation in immuno-oncology drugs has supported the moats for Merck & Co Inc. (MRK...

Logo
558 Views
Share
x